Other Assets, Current in USD of Ambrx Biopharma Cayman, Inc. from Q4 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Ambrx Biopharma Cayman, Inc. quarterly Other Assets, Current history and change rate from Q4 2020 to Q2 2023.
  • Ambrx Biopharma Cayman, Inc. Other Assets, Current for the quarter ending 30 Jun 2023 was $981,000, a 0.51% decline year-over-year.
Source SEC data
View on sec.gov
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Change (%)

Ambrx Biopharma Cayman, Inc. Quarterly Other Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $981,000 -$5,000 -0.51% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $238,000 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $487,000 +$257,000 +112% 31 Dec 2022 10-Q 09 Aug 2023 2023 Q2
Q2 2022 $986,000 30 Jun 2022 6-K 29 Aug 2022 2022 Q2
Q4 2021 $230,000 +$39,000 +20.4% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q4 2020 $191,000 31 Dec 2020 20-F 26 Apr 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.